ANC 0 3 0 3 B-clinical_variable
/ 3 4 3 4 O
AGC 4 7 4 7 B-clinical_variable
≥750 8 12 8 12 O
/ 12 13 12 13 I-lower_bound
uL 13 15 13 15 I-lower_bound

AST 0 3 16 19 B-clinical_variable
, 3 4 19 20 O
ALT 5 8 21 24 B-clinical_variable
≤ 9 10 25 26 O
3.0 11 14 27 30 B-upper_bound
X 15 16 31 32 I-upper_bound
ULN 17 20 33 36 I-upper_bound
, 20 21 36 37 O
or 22 24 38 40 O
≤ 25 26 41 42 O
5.0 27 30 43 46 B-upper_bound
X 31 32 47 48 I-upper_bound
ULN 33 36 49 52 I-upper_bound

Absolute 0 8 53 61 B-clinical_variable
Lymphocytes 9 20 62 73 I-clinical_variable
≥800 21 25 74 78 O
/ 25 26 78 79 I-lower_bound
uL 26 28 79 81 I-lower_bound

Adrenal 0 7 82 89 B-treatment
replacement 8 19 90 101 I-treatment
steroid 20 27 102 109 I-treatment
doses 28 33 110 115 I-treatment
≤ 34 35 116 117 O
10 36 38 118 120 B-upper_bound
mg 39 41 121 123 I-upper_bound
daily 42 47 124 129 O
prednisone 48 58 130 140 B-treatment
equivalent 59 69 141 151 O
are 70 73 152 155 O
permitted 74 83 156 165 O
in 84 86 166 168 O
the 87 90 169 172 O
absence 91 98 173 180 O
of 99 101 181 183 O
active 102 108 184 190 O
autoimmune 109 119 191 201 B-chronic_disease
disease 120 127 202 209 I-chronic_disease

Anti 0 4 210 214 B-chronic_disease
- 4 5 214 215 I-chronic_disease
CD20 5 9 215 219 I-chronic_disease
mAb 10 13 220 223 I-chronic_disease
- 13 14 223 224 I-chronic_disease
refractory 14 24 224 234 I-chronic_disease
disease 25 32 235 242 I-chronic_disease
is 33 35 243 245 O
defined 36 43 246 253 O
as 44 46 254 256 O
progressive 47 58 257 268 O
disease 59 66 269 276 O
while 67 72 277 282 O
on 73 75 283 285 O
rituximab 76 85 286 295 O
( 86 87 296 297 O
or 87 89 297 299 O
another 90 97 300 307 O
treatment 98 107 308 317 B-treatment
of 108 110 318 320 I-treatment
an 111 113 321 323 I-treatment
anti 114 118 324 328 I-treatment
- 118 119 328 329 I-treatment
CD20 119 123 329 333 I-treatment
monoclonal 124 134 334 344 O
antibody 135 143 345 353 O
) 143 144 353 354 O
or 145 147 355 357 O
progression 148 159 358 369 O
within 160 166 370 376 O
6 167 168 377 378 B-upper_bound
months 169 175 379 385 I-upper_bound
of 176 178 386 388 O
rituximab 179 188 389 398 O
- 188 189 398 399 O
containing 189 199 399 409 O
( 200 201 410 411 O
or 201 203 411 413 O
another 204 211 414 421 O
treatment 212 221 422 431 O
of 222 224 432 434 O
an 225 227 435 437 O
anti 228 232 438 442 O
- 232 233 442 443 O
CD20 233 237 443 447 O
antibody 238 246 448 456 O
- 246 247 456 457 O
containing 247 257 457 467 O
) 257 258 467 468 O
therapy 259 266 469 476 B-treatment

Anti 0 4 477 481 O
- 4 5 481 482 O
CD20 5 9 482 486 O
mAb 10 13 487 490 O
- 13 14 490 491 O
sensitive 14 23 491 500 O
disease 24 31 501 508 O
is 32 34 509 511 O
defined 35 42 512 519 O
by 43 45 520 522 O
a 46 47 523 524 O
response 48 56 525 533 O
to 57 59 534 536 O
a 60 61 537 538 O
prior 62 67 539 544 O
rituximab 68 77 545 554 B-treatment
- 77 78 554 555 O
containing 78 88 555 565 O
( 89 90 566 567 O
or 90 92 567 569 O
another 93 100 570 577 O
treatment 101 110 578 587 B-treatment
of 111 113 588 590 O
an 114 116 591 593 O
anti 117 121 594 598 O
- 121 122 598 599 O
CD20 122 126 599 603 O
monoclonal 127 137 604 614 O
antibody 138 146 615 623 O
) 146 147 623 624 O
regimen 148 155 625 632 O
, 155 156 632 633 O
and 157 160 634 637 O
relapse 161 168 638 645 O
more 169 173 646 650 O
than 174 178 651 655 O
6 179 180 656 657 B-upper_bound
months 181 187 658 664 I-upper_bound
from 188 192 665 669 O
the 193 196 670 673 O
last 197 201 674 678 O
administration 202 216 679 693 O
of 217 219 694 696 O
rituximab 220 229 697 706 O
- 229 230 706 707 O
containing 230 240 707 717 O
( 241 242 718 719 O
or 242 244 719 721 O
another 245 252 722 729 O
treatment 253 262 730 739 O
of 263 265 740 742 O
an 266 268 743 745 O
anti 269 273 746 750 O
- 273 274 750 751 O
CD20 274 278 751 755 O
antibody 279 287 756 764 O
- 287 288 764 765 O
containing 288 298 765 775 O
) 298 299 775 776 O
therapy 300 307 777 784 B-treatment

At 0 2 785 787 O
least 3 8 788 793 O
one 9 12 794 797 B-lower_bound
lymph 13 18 798 803 B-clinical_variable
node 19 23 804 808 I-clinical_variable
group 24 29 809 814 I-clinical_variable
≥ 30 31 815 816 O
1.5 32 35 817 820 B-lower_bound
cm 36 38 821 823 I-lower_bound
in 39 41 824 826 O
longest 42 49 827 834 O
transverse 50 60 835 845 O
dimension 61 70 846 855 O

ECOG 0 4 856 860 B-clinical_variable
0 5 6 861 862 B-lower_bound
, 6 7 862 863 O
1 8 9 864 865 O
, 9 10 865 866 O
or 11 13 867 869 O
2 14 15 870 871 B-upper_bound

Glomerular 0 10 872 882 B-clinical_variable
Filtration 11 21 883 893 I-clinical_variable
Rate 22 26 894 898 I-clinical_variable
( 27 28 899 900 I-clinical_variable
GFR 28 31 900 903 I-clinical_variable
) 31 32 903 904 I-clinical_variable
> 33 34 905 906 O
40mL 35 39 907 911 B-lower_bound
/ 39 40 911 912 I-lower_bound
min 40 43 912 915 I-lower_bound

Hemoglobin 0 10 916 926 B-clinical_variable
≥ 11 12 927 928 O
8g 13 15 929 931 B-lower_bound
/ 15 16 931 932 I-lower_bound
dL 16 18 932 934 I-lower_bound

Histologically 0 14 935 949 O
confirmed 15 24 950 959 O
diagnosis 25 34 960 969 O
of 35 37 970 972 O
iNHL 38 42 973 977 B-cancer
( 43 44 978 979 O
Follicular 44 54 979 989 B-cancer
lymphoma 55 63 990 998 I-cancer
grade 64 69 999 1004 I-cancer
1 70 71 1005 1006 I-cancer
, 71 72 1006 1007 I-cancer
2 73 74 1008 1009 I-cancer
, 74 75 1009 1010 I-cancer
3a 76 78 1011 1013 I-cancer
; 78 79 1013 1014 O
marginal 80 88 1015 1023 B-cancer
zone 89 93 1024 1028 I-cancer
lymphoma 94 102 1029 1037 I-cancer
; 102 103 1037 1038 O
small 104 109 1039 1044 B-cancer
lymphocytic 110 121 1045 1056 I-cancer
lymphoma 122 130 1057 1065 I-cancer
or 131 133 1066 1068 O
lymphoplasmacytic 134 151 1069 1086 B-cancer
lymphoma 152 160 1087 1095 I-cancer
) 160 161 1095 1096 O
after 162 167 1097 1102 O
treatment 168 177 1103 1112 B-treatment
with 178 182 1113 1117 O
at 183 185 1118 1120 O
least 186 191 1121 1126 O
1 192 193 1127 1128 O
or 194 196 1129 1131 O
more 197 201 1132 1136 O
prior 202 207 1137 1142 B-treatment
rituximab 208 217 1143 1152 I-treatment
- 217 218 1152 1153 I-treatment
containing 218 228 1153 1163 I-treatment
regimens 229 237 1164 1172 I-treatment

Must 0 4 1173 1177 O
have 5 9 1178 1182 O
recovered 10 19 1183 1192 O
from 20 24 1193 1197 O
side 25 29 1198 1202 O
effects 30 37 1203 1210 O
of 38 40 1211 1213 O
prior 41 46 1214 1219 B-treatment
treatments 47 57 1220 1230 I-treatment

Negative 0 8 1231 1239 B-pregnancy
serum 9 14 1240 1245 I-pregnancy
pregnancy 15 24 1246 1255 I-pregnancy
test 25 29 1256 1260 O
if 30 32 1261 1263 O
female 33 39 1264 1270 B-gender
and 40 43 1271 1274 O
of 44 46 1275 1277 O
childbearing 47 59 1278 1290 O
potential 60 69 1291 1300 O

No 0 2 1301 1303 O
NYHA 3 7 1304 1308 B-clinical_variable
Class 8 13 1309 1314 I-clinical_variable
> 14 15 1315 1316 O
II 16 18 1317 1319 B-lower_bound
CHF 19 22 1320 1323 B-chronic_disease

No 0 2 1324 1326 O
active 3 9 1327 1333 O
CNS 10 13 1334 1337 O
involvement 14 25 1338 1349 O
with 26 30 1350 1354 O
lymphoma 31 39 1355 1363 B-cancer

No 0 2 1364 1366 O
active 3 9 1367 1373 B-chronic_disease
systemic 10 18 1374 1382 I-chronic_disease
infection 19 28 1383 1392 I-chronic_disease
requiring 29 38 1393 1402 O
parenteral 39 49 1403 1413 B-treatment
antibiotic 50 60 1414 1424 I-treatment
therapy 61 68 1425 1432 I-treatment

No 0 2 1433 1435 O
anti 3 7 1436 1440 B-treatment
- 7 8 1440 1441 I-treatment
lymphoma 8 16 1441 1449 I-treatment
treatments 17 27 1450 1460 I-treatment
within 28 34 1461 1467 O
28 35 37 1468 1470 B-upper_bound
days 38 42 1471 1475 I-upper_bound
before 43 49 1476 1482 I-upper_bound
the 50 53 1483 1486 O
start 54 59 1487 1492 O
of 60 62 1493 1495 O
study 63 68 1496 1501 O
treatment 69 78 1502 1511 O

No 0 2 1512 1514 O
congestive 3 13 1515 1525 B-clinical_variable
heart 14 19 1526 1531 I-clinical_variable
failure 20 27 1532 1539 I-clinical_variable
< 28 29 1540 1541 O
6 30 31 1542 1543 B-upper_bound
months 32 38 1544 1550 I-upper_bound

No 0 2 1551 1553 O
disease 3 10 1554 1561 O
requiring 11 20 1562 1571 O
systemic 21 29 1572 1580 O
immunosuppressive 30 47 1581 1598 B-treatment
therapy 48 55 1599 1606 I-treatment

No 0 2 1607 1609 O
history 3 10 1610 1617 O
of 11 13 1618 1620 O
uncontrollable 14 28 1621 1635 O
supraventricular 29 45 1636 1652 B-chronic_disease
arrhythmias 46 57 1653 1664 I-chronic_disease

No 0 2 1665 1667 O
history 3 10 1668 1675 O
of 11 13 1676 1678 O
ventricular 14 25 1679 1690 B-chronic_disease
arrhythmias 26 37 1691 1702 I-chronic_disease
or 38 40 1703 1705 O
severe 41 47 1706 1712 O
cardiac 48 55 1713 1720 B-chronic_disease
dysfunction 56 67 1721 1732 I-chronic_disease

No 0 2 1733 1735 O
known 3 8 1736 1741 O
autoimmune 9 19 1742 1752 B-chronic_disease
disease 20 27 1753 1760 I-chronic_disease
other 28 33 1761 1766 O
than 34 38 1767 1771 O
corrected 39 48 1772 1781 O
hypothyroidism 49 63 1782 1796 B-chronic_disease

No 0 2 1797 1799 O
known 3 8 1800 1805 O
histologic 9 19 1806 1816 O
transformation 20 34 1817 1831 O
from 35 39 1832 1836 O
iNHL 40 44 1837 1841 B-cancer
to 45 47 1842 1844 O
DLBCL 48 53 1845 1850 B-cancer

No 0 2 1851 1853 O
known 3 8 1854 1859 O
prior 9 14 1860 1865 B-treatment
organ 15 20 1866 1871 I-treatment
allograft 21 30 1872 1881 I-treatment
or 31 33 1882 1884 O
allogeneic 34 44 1885 1895 B-treatment
transplantation 45 60 1896 1911 I-treatment

No 0 2 1912 1914 O
myocardial 3 13 1915 1925 B-chronic_disease
infarction 14 24 1926 1936 I-chronic_disease
< 25 26 1937 1938 O
6 27 28 1939 1940 B-upper_bound
months 29 35 1941 1947 I-upper_bound

No 0 2 1948 1950 O
positive 3 11 1951 1959 O
Hep 12 15 1960 1963 B-chronic_disease
C 16 17 1964 1965 I-chronic_disease
serology 18 26 1966 1974 O
or 27 29 1975 1977 O
active 30 36 1978 1984 O
Hep 37 40 1985 1988 B-chronic_disease
B 41 42 1989 1990 I-chronic_disease
infection 43 52 1991 2000 O

No 0 2 2001 2003 O
psychiatric 3 14 2004 2015 B-chronic_disease
illness 15 22 2016 2023 I-chronic_disease
/ 22 23 2023 2024 O
social 23 29 2024 2030 O
situation 30 39 2031 2040 O
that 40 44 2041 2045 O
would 45 50 2046 2051 O
limit 51 56 2052 2057 O
compliance 57 67 2058 2068 O

No 0 2 2069 2071 O
unstable 3 11 2072 2080 B-clinical_variable
angina 12 18 2081 2087 I-clinical_variable
pectoris 19 27 2088 2096 I-clinical_variable
< 28 29 2097 2098 O
6 30 31 2099 2100 B-upper_bound
months 32 38 2101 2107 I-upper_bound

Not 0 3 2108 2111 O
HIV 4 7 2112 2115 B-chronic_disease
positive 8 16 2116 2124 O

Platelets 0 9 2125 2134 B-clinical_variable
≥30,000 10 17 2135 2142 O
/ 17 18 2142 2143 I-lower_bound
uL 18 20 2143 2145 I-lower_bound

Relapsed 0 8 2146 2154 B-cancer
or 9 11 2155 2157 I-cancer
Refractory 12 22 2158 2168 I-cancer
iNHL 23 27 2169 2173 I-cancer
that 28 32 2174 2178 O
has 33 36 2179 2182 O
progressed 37 47 2183 2193 O
during 48 54 2194 2200 O
or 55 57 2201 2203 O
following 58 67 2204 2213 O
1 68 69 2214 2215 B-lower_bound
or 70 72 2216 2218 O
more 73 77 2219 2223 O
prior 78 83 2224 2229 B-treatment
systemic 84 92 2230 2238 I-treatment
rituximab 93 102 2239 2248 I-treatment
- 102 103 2248 2249 I-treatment
containing 103 113 2249 2259 I-treatment
( 114 115 2260 2261 I-treatment
or 115 117 2261 2263 I-treatment
another 118 125 2264 2271 I-treatment
treatment 126 135 2272 2281 I-treatment
of 136 138 2282 2284 I-treatment
an 139 141 2285 2287 I-treatment
anti 142 146 2288 2292 I-treatment
- 146 147 2292 2293 I-treatment
CD20 147 151 2293 2297 I-treatment
antibody 152 160 2298 2306 I-treatment
- 160 161 2306 2307 I-treatment
containing 161 171 2307 2317 I-treatment
) 171 172 2317 2318 I-treatment
regimens 173 181 2319 2327 I-treatment
for 182 185 2328 2331 O
lymphoma 186 194 2332 2340 B-cancer

Serum 0 5 2341 2346 B-clinical_variable
creatinine 6 16 2347 2357 I-clinical_variable
≤ 17 18 2358 2359 O
1.5 19 22 2360 2363 B-upper_bound
X 23 24 2364 2365 I-upper_bound
ULN 25 28 2366 2369 I-upper_bound

Subjects 0 8 2370 2378 O
, 8 9 2378 2379 O
both 10 14 2380 2384 O
females 15 22 2385 2392 B-gender
and 23 26 2393 2396 O
males 27 32 2397 2402 O
, 32 33 2402 2403 O
with 34 38 2404 2408 O
reproductive 39 51 2409 2421 O
potential 52 61 2422 2431 O
must 62 66 2432 2436 O
agree 67 72 2437 2442 B-contraception_consent
to 73 75 2443 2445 I-contraception_consent
use 76 79 2446 2449 I-contraception_consent
effective 80 89 2450 2459 I-contraception_consent
contraceptive 90 103 2460 2473 I-contraception_consent
measures 104 112 2474 2482 I-contraception_consent
for 113 116 2483 2486 O
the 117 120 2487 2490 O
duration 121 129 2491 2499 O
of 130 132 2500 2502 O
the 133 136 2503 2506 O
study 137 142 2507 2512 O

Total 0 5 2513 2518 B-clinical_variable
bilirubin 6 15 2519 2528 I-clinical_variable
≤ 16 17 2529 2530 O
2.0 18 21 2531 2534 B-upper_bound
X 22 23 2535 2536 I-upper_bound
ULN 24 27 2537 2540 I-upper_bound
( 28 29 2541 2542 O
unless 29 35 2542 2548 O
Gilbert 36 43 2549 2556 B-chronic_disease
's 43 45 2556 2558 I-chronic_disease
Syndrome 46 54 2559 2567 I-chronic_disease
or 55 57 2568 2570 O
disease 58 65 2571 2578 O
infiltration 66 78 2579 2591 O
of 79 81 2592 2594 O
liver 82 87 2595 2600 O
is 88 90 2601 2603 O
present 91 98 2604 2611 O
) 98 99 2611 2612 O

Women 0 5 2613 2618 B-gender
who 6 9 2619 2622 O
are 10 13 2623 2626 O
not 14 17 2627 2630 B-pregnancy
pregnant 18 26 2631 2639 I-pregnancy
or 27 29 2640 2642 O
nursing 30 37 2643 2650 O

